Immunotherapy of the Paraneoplastic Syndromes

NCT00378326 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Rockefeller University